GASTROENTEROLOGY PSI is a leading, full-service CRO specializing in on-time delivery of clinical studies. PSI positions itself as a ‘no-nonsense’ CRO capable of saving our sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. In the past few years, PSI has conducted many gastroenterology studies. All of these studies completed enrollment on–time or ahead of schedule. In an industry where >90% of studies fall behind enrollment deadlines, our clients find this statistic refreshing. PSI has qualified gastroenterologists in our Project Management, Operational and Medical Monitoring teams. This enables us to draw on our historical experience and to incorporate current practice into preparing and overcoming the key challenges faced during today’s studies. With a low staff turnover rate of <6%, PSI continues to accumulate knowledge in the conduct of studies in gastroenterology. PSI’s dedicated Feasibility Department, comprised of medical specialists, laboratory experts, imaging specialists, logisticians and regulatory experts, has conducted feasibility across a wide range of gastroenterological indications. When we apply this process to your trial and combine it with our familiarity of the nuances and complexities associated with studies in diseases of the GI Tract, we are able to provide recommendations for the best choice of sites, geography and realistic timelines for your study.
A timely delivery of our first major Milestone! Thank you all for making this possible. As always we can depend so much on your projections and expertise. Doing studies with the PSI team is so much fun, since you never have to worry.
For more information about PSI, please visit our website WWW.PSI-CRO.COM or reach us at CONTACT@PSI-CRO.COM
Clinical Project Manager, Austria
PSI has the following Phase I-IV experience in diseases affecting the GI tract and the organs of the abdominal cavity: Colorectal Cancer
Hepatitis B & C
Chemo Induced Diarrhea
Hepatocellular Cancer
Crohn’s Disease
Pancreatic Cancer
Gastric Cancer
Short Bowel Syndrome
Gastroesophageal Cancer
Ulcerative Colitis
GERD
WWW.PSI-CRO.COM PSI CRO AG Corporate Headquarters Baarerstrasse 113a, 6300 Zug, Switzerland • Tel: +41 41 228 10 00
Global Office Locations North America: Ft. Washington, PA / Burlingame, CA / San Francisco, CA Latin America: Buenos Aires, Argentina Europe: Oxford, UK / Munich, Germany / Neusiedl am See, Austria Minsk, Belarus / Sofia, Bulgaria / Prague, Czech Republic / Tallinn, Estonia Budapest, Hungary / Milan, Italy / Warsaw, Poland / Bucharest, Romania Belgrade, Serbia / Kiev, Ukraine Russian Federation: St. Petersburg, Moscow, Novosibirsk
Operational Presence by Region North America / Europe / Latin America Asia-Pacific / South Africa